Ryunosuke Saiki¹, Yusuke Shiozawa², Tetsuichi Yoshizato¹, Yasuhito Nanya¹, June Takeda¹, Kenichi Yoshida¹, Yuichi Shiraishi³, Hiroko Tanaka³, Kenichi Chiba³, Yoshiko Atsuta⁴, Makoto Onizuka⁵, Hidehiro Itonaga⁶, Masashi Sanada⁷, Yoshinobu Kanda⁸, Przychodzen Bartlomiej⁹, Sekeres Mikkael^9,10, Guinta Kathryn⁹, Saunthararajah Yogen⁹, Yasushi Miyazaki⁶, Shigeru Chiba¹⁰, Senji Kasahara¹¹, Toru Kiguchi¹², Hisashi Tsurumi¹³, Malcovati Luca^14,15, Cazzola Mario¹⁵, Takayuki Ishikawa¹⁶, Satoru Miyano³, Maciejewski Jaroslaw⁹, Hideki Makishima^1,9, Seishi Ogawa¹ (1.Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 3.Human Genome Center, The University of Tokyo, Tokyo, Japan, 4.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 5.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 6.Department of Hematology, Nagasaki University, Nagasaki, Japan, 7.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 8.Division of Hematology, Jichi Medical University, Saitama, Japan, 9.Cleveland Clinic, Cleveland, OH, United States, 10.Department of Hematology, University of Tsukuba, Tsukuba, Ibaraki, Japan, 11.Department of Hematology, Gifu Municipal University, Gifu, Japan, 12.Department of Hematology, Chugoku Central Hospital, Fukuyama, Hiroshima, Japan, 13.Department of Hematology, Gifu University, Gifu, Japan, 14.Department of Hematology Oncology, University of Pavia, Pavia, Italy, 15.Department of Molecular Medicine, University of Pavia, Pavia, Italy, 16.Department of Hematology, Kobe City Medical Center, Kobe, Japan)

Yasuhito Nanya¹, Shinya Sato², Tetsuichi Yoshizato¹, Yasunobu Nagata¹, June Takeda¹, Lanying Zhao¹, Yuichi Shiraishi³, Kenichi Chiba³, Hiroko Tanaka³, Hisashi Tsurumi⁴, Senji Kasahara⁵, Toru Kiguchi⁶, Takayuki Ishikawa⁷, Shigeru Chiba⁸, Yasunori Ueda⁹, Kazunori Imada¹⁰, Kensuke Usuki¹¹, Akifumi Takaori¹², Kazuma Ohyashiki¹³, Yasushi Miyazaki^2,14, Hideki Makishima¹, Yoshiko Atsuta¹⁵, Satoru Miyano³, Seishi Ogawa^1,16 (1.Pathology & Tumor Biology, Kyoto University, Kyoto, Japan, 2.Department of Hematology, Nagasaki University, Nagasaki, Japan, 3.Human Genome Center, IMSUT, Tokyo, Japan, 4.Department of Hematology, Gifu University, Gifu, Japan, 5.Department of Hematology, Gifu Municipal Hospital, Gifu, Japan, 6.Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan, 7.Department of Hematology, KCMCGH, Kobe, Japan, 8.Department of Hematology, Tsukuba University, Tsukuba, Japan, 9.Department of Hematology, Kurashiki Central Hospital, Kurashiki, Japan, 10.Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan, 11.Department of Hematology, NTT-East Hospital, Tokyo, Japan, 12.Department of Hematology, Kyoto University, Kyoto, Japan, 13.Department of Hematology, Tokyo Medical University, Tokyo, Japan, 14.Japan Adult Leukemia Study Group, Nagasaki, Japan, 15.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 16.Karolinska Institute, Stockholm, Sweden)

Ken Sasaki¹, Masashi Miyauchi¹, Kazuki Taoka¹, Yosuke Masamoto¹, Sho Yamazaki¹, Shunya Arai¹, Yuki Kagoya², Mineo Kurokawa^1,2 (1.Hematology and Oncology, Tokyo Univ., Tokyo, Japan, 2.Cell Therapy and Transplantation Medicine, Tokyo Univ., Tokyo, Japan)

Xingxing Qi¹, Masahiro M Nakagawa^1,2, Ryosaku Inagaki^1,2,3, Sosuke Sumiyoshi¹, Tomoe Nakagawa¹, Yasuhito Nanya¹, Zhao Lanying^1,5, Hideki Makishima¹, Hisashi Tsurumi⁴, Seishi Ogawa^1,2,5,6 (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.DSK Project, Medical Innovation Center, Kyoto University, Kyoto, Japan, 3.DSP Cancer Institute, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan, 4.Department of Hematology, Gifu University, Gifu, Japan, 5.Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan, 6.Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sodermanland and Uppland, Kingdom of Sweden)

Daisuke Shinoda^1,2, Yaeko Nakajima¹, Motohiko Oshima¹, Hironori Harada³, Haruhiko Koseki⁴, Kazuya Shimoda⁵, Goro Sashida⁶, Atsushi Iwama¹ (1.Division of Stem Cell and Molecular Medicine, IMSUT, Tokyo, Japan, 2.Department of Molecular Diagnosis, Chiba University, Chiba, Japan, 3.Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan, 4.RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 5.Department of Gastroenterology and Hematology, Miyazaki University, Miyazaki, Japan, 6.International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan)

Yoko Edahiro¹, Chang Liu¹, Marito Araki², Mai Nudejima¹, Soji Morishita², Misa Imai^1,3, Nami Masubuchi^1,4, Yoshihisa Mizukami^1,5, Shuichi Mano¹, Hiraku Takei¹, Akimichi Ohsaka², Norio Komatsu¹ (1.Hematology, Juntendo Univ., Tokyo, Japan, 2.Transfusion Medicine and Stem Cell Regulation, Juntendo Univ., Tokyo, Japan, 3.Development and Research of Cancer Medicine, Juntendo Univ., Tokyo, Japan, 4.Disease of Old Age, Juntendo Univ., Tokyo, Japan, 5.Center for Genomic and Regenerative Medicine, Juntendo Univ., Tokyo, Japan)